Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ketanserin

"Ketanserin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.


This graph shows the total number of publications written about "Ketanserin" by people in Harvard Catalyst Profiles by year, and whether "Ketanserin" was a major or minor topic of these publication.
Bar chart showing 19 publications over 15 distinct years, with a maximum of 2 publications in 1995 and 2002 and 2004 and 2007
To see the data from this visualization as text, click here.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.